HomeDTC • CNSX
add
Defence Therapeutics Inc
Previous close
$0.77
Day range
$0.77 - $0.84
Year range
$0.49 - $1.66
Market cap
42.14M CAD
Avg Volume
70.65K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 767.20K | -20.81% |
Net income | -951.89K | 28.31% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -749.49K | 21.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.08M | 304.19% |
Total assets | 2.36M | 144.10% |
Total liabilities | 2.58M | -20.89% |
Total equity | -219.72K | — |
Shares outstanding | 54.73M | — |
Price to book | ∞ | — |
Return on assets | -138.65% | — |
Return on capital | 384.74% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -951.89K | 28.31% |
Cash from operations | -2.00M | -112.12% |
Cash from investing | -2.00 | 100.00% |
Cash from financing | 3.95M | 199.29% |
Net change in cash | 1.95M | 1,091.89% |
Free cash flow | -1.50M | -156.41% |
About
Founded
2017
Headquarters
Website
